Drug intelligence / Profile preview

RS-004

Development stage: Preclinical
Lead developer: Related Sciences
Administration: Oral

Overview

RS-004 is a preclinical-stage therapeutic candidate under development by Related Sciences for the treatment of oncology indications. The program is currently in the IND-enabling (Investigational New Drug) phase of development. Specific details regarding its molecular target, mechanism of action, and exact modality have not been publicly disclosed.

Beyond the preview

Go deeper on RS-004.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RS-004.

Explore the full profile